KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Gains from Sales and Divestitures (2016 - 2017)

Historic Gains from Sales and Divestitures for Tenet Healthcare (THC) over the last 9 years, with Q1 2017 value amounting to $960836.0.

  • Tenet Healthcare's Gains from Sales and Divestitures fell 2143.71% to $960836.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $960836.0, marking a year-over-year decrease of 2143.71%. This contributed to the annual value of $1.6 million for FY2016, which is 3590.08% up from last year.
  • Per Tenet Healthcare's latest filing, its Gains from Sales and Divestitures stood at $960836.0 for Q1 2017, which was down 2143.71% from $1.6 million recorded in Q4 2016.
  • In the past 5 years, Tenet Healthcare's Gains from Sales and Divestitures ranged from a high of $1.6 million in Q4 2016 and a low of $839353.0 during Q1 2014
  • Its 5-year average for Gains from Sales and Divestitures is $1.1 million, with a median of $996363.0 in 2015.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first plummeted by 7604.24% in 2013, then skyrocketed by 4141.06% in 2016.
  • Over the past 5 years, Tenet Healthcare's Gains from Sales and Divestitures (Quarter) stood at $966838.0 in 2013, then rose by 4.46% to $1.0 million in 2014, then increased by 19.83% to $1.2 million in 2015, then skyrocketed by 35.9% to $1.6 million in 2016, then plummeted by 41.58% to $960836.0 in 2017.
  • Its Gains from Sales and Divestitures stands at $960836.0 for Q1 2017, versus $1.6 million for Q4 2016 and $1.5 million for Q3 2016.